Rationale and design of the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE)Steven Grinspoon, Pamela S. Douglas, Karin L. Klingman et al.|American Heart Journal|2019Cited by 153
Rationale and design of the Mechanistic Substudy of the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE): Effects of pitavastatin on coronary artery disease and inflammatory biomarkersUdo Hoffmann, Steven Grinspoon, Michael T. Lu et al.|American Heart Journal|2019Cited by 63
Correlates and Timing of Reproductive Aging Transitions in a Global Cohort of Midlife Women With Human Immunodeficiency Virus: Insights From the REPRIEVE TrialMarkella V. Zanni, Sara E. Looby, Judith S. Currier et al.|The Journal of Infectious Diseases|2020Cited by 25
Successful recruitment of a multi-site international randomized placebo-controlled trial in people with HIV with attention to diversity of race and ethnicity: critical role of central coordinationKathleen V. Fitch, Emma M. Kileel, Sara E. Looby et al.|HIV Research & Clinical Practice|2020Cited by 10
Characteristics of REPRIEVE Trial Participants Identifying Across the Transgender SpectrumLaura Smeaton, Karin L. Klingman, Emma M. Kileel et al.|The Journal of Infectious Diseases|2020Cited by 6